A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Google alert failed to warn people of Turkey earthquake
WhatsApp faces first fine in Russia for failure to delete 'banned' content
The best dating apps and sites in June 2023
Virginia finalizes guidance on transgender students, including rolling back some accommodations
Dish Wireless: We’ll Meet June Deadline to Cover 70% of Americans With 5G
Oil producers say tech will soon handle climate-wrecking fumes. US envoy Kerry says be skeptical
Is Diablo 4 on Mac?
The best free agents to sign on Football Manager 2024